major adverse cardiac events
the value of global longitudinal 2D echocardiography in predicting major adverse cardiac events (MACE) and mortality in patients with acute coronary syndrome (ACS) and reduced left ventricular ejection fraction (LVEF).
the value of global longitudinal 2D echocardiography in predicting major adverse cardiac events ( MACE ) and mortality in patients with acute coronary syndrome ( ACS ) and reduced left ventricular ejection fraction ( LVEF ) .